Skip to content

Medical-device intelligence

MVC: System, Test, Her-2/Neu, Ihc

FDA product code MVC: System, Test, Her-2/Neu, Ihc. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MVC
FDA device name
System, Test, Her-2/Neu, Ihc
Device class
3
Regulation number
Not provided
Medical specialty
Unknown
Review panel
PA

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 8 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Sep 29, 2005 to Jul 1, 2014.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
MVC · System, Test, Her-2/Neu, Ihc08

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
InSite HER-2 Detection Kit, an immunohistochemistry assay for in vitro diagnostic use.Z-2113-2014 · MVCBiogenex Laboratories, Inc.RecallJul 24, 2014FDA classification date
VENTANA PATHWAY anti-HER-2/neu (4B5) RABBIT MONOCLONAL PRIMARY ANTIBODY (PATHWAY HER2 (4B5)); Model Number: 790-2991, Lot number: 680957, in vitr…Z-1146-2010 · MVCVentana Medical Systems IncRecallMar 16, 2010FDA classification date
Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu IHC Ki…Z-0606-06 · MVCBiogenex LaboratoriesRecallMar 15, 2006FDA classification date
Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu IHC Ki…Z-0607-06 · MVCBiogenex LaboratoriesRecallMar 15, 2006FDA classification date
Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu Monocl…Z-0608-06 · MVCBiogenex LaboratoriesRecallMar 15, 2006FDA classification date
Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu Monocl…Z-0609-06 · MVCBiogenex LaboratoriesRecallMar 15, 2006FDA classification date
K 520411-2, Hercep Test, 35Test, HER2, ProteinZ-0113-06 · MVCDakocytomation California IncRecallNov 1, 2005FDA classification date
K 520711-2, Hercep Test, 35Test, HER2, ProteinZ-0114-06 · MVCDakocytomation California IncRecallNov 1, 2005FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗